Filing Details
- Accession Number:
- 0000950170-24-067989
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-03 16:21:12
- Reporting Period:
- 2024-05-30
- Accepted Time:
- 2024-06-03 16:21:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339970 | Atyr Pharma Inc | LIFE | Biological Products, (No Disgnostic Substances) (2836) | 203435077 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376043 | Timothy Coughlin | C/O Atyr Pharma, Inc. 10240 Sorrento Valley Road, Suite 300 San Diego CA 92121 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-30 | 50,000 | $1.75 | 56,000 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnote |
Footnotes
- Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.665 to $1.80 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- These shares are owned by the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person and his spouse serve as co-trustees of the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person may be deemed to be the beneficial owner of the securities held by the Coughlin Family Trust u/a DTD 12/07/2006.
Billionaire Hedge Funds
